Pilot and definitive randomised double-blind placebo-controlled trials evaluating an oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting (CINV).

Antony J Mersiades,Annette Tognela,Paul S. Haber,Martin R. Stockler,Nicholas Lintzeris,Iain S. McGregor,Ian Olver,David J. Allsop,Craig Gedye,Adrienne Kirby,Rachael L. Morton,Anh Tran,Karen P. Briscoe,Peter Fox,Stephen Clarke,Morteza Aghmesheh,Nicole Wong,Anna Walsh,Carmel Hahn,Peter Grimison

Pilot and definitive randomised double-blind placebo-controlled trials evaluating an oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting (CINV).

2018

TPS10128Background: Up to half of patients receiving chemotherapy of moderate or high emetic risk experience CINV despite optimal anti-emetic prophylaxis. Limited evidence suggests cannabinoid medi...

Keywords:

Cannabis
Placebo
Cannabinoid
Physical therapy
Chemotherapy-induced nausea and vomiting
Medicine
Chemotherapy
limited evidence
secondary prevention
Internal medicine
double blind

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations